title: Therapeutic options in systemic AL amyloidosis.
abstract: Systemic amyloid light chain (AL) amyloidosis is a severe disease with unfavourable prognosis. Since the late 1970s different therapeutic modalities in AL amyloidosis have been investigated, trying to prolong survival. This review deals with the therapeutic modalities in AL amyloidosis to date, and highlights future perspectives.
authors.affiliation: Department of Rheumatology, University Hospital Groningen, The Netherlands. iivangameren@xs4all.nl
authors.forename: I I
authors.initials: II
authors.lastname: van Gameren
authors.forename: H
authors.initials: H
authors.lastname: Lokhorst
authors.forename: B P C
authors.initials: BP
authors.lastname: Hazenberg
authors.forename: E
authors.initials: E
authors.lastname: Vellenga
mesh_terms: D000686:Amyloidosis / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D007147:Immunoglobulin Light Chains / Q000502:physiology; D000685:Serum Amyloid A Protein / Q000502:physiology
chemical_list: D007147:Immunoglobulin Light Chains; D000685:Serum Amyloid A Protein